HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1β secretion in diabetic mice.


Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
01 11 2020
Historique:
received: 15 11 2019
revised: 18 07 2020
accepted: 20 07 2020
pubmed: 28 7 2020
medline: 15 12 2020
entrez: 27 7 2020
Statut: ppublish

Résumé

Delayed wound healing in diabetes is characterized by sustained activation of inflammasome and increased expression of IL-1β in macrophages. Identification and validation of novel pathways to regulate IL-1β expression will provide therapeutic targets for diabetic wounds. Here we report sustained over-expression of histone deacetylase 6 (HDAC6) in wounds of diabetic mice and its role in delayed wound healing. Topical application of HDAC6 inhibitor; Tubastatin A (TSA) gel promoted the wound healing in diabetic mice. TSA hydrogel reduced the infiltration of neutrophils, T-cells and macrophages in the early phase of wound healing. TSA treatment promoted the wound healing by inducing collagen deposition, angiogenesis (CD31) and fibrotic factors (TGF-β1) in the late phase of healing. Protein analysis of the diabetic wounds treated with TSA showed increased acetylated α-tubulin and decreased levels of mature IL-1β with no significant effect on the expression of pro-IL-1β, pro-caspase-1 and active caspase-1. In in vitro assays, macrophages exhibited upregulation of HDAC6, IL-1β and downregulation of IL-10 upon stimulation with high glucose and LPS. TSA inhibited the IL-1β secretion and promoted IL-10 in stimulated macrophages with high glucose and LPS. Further investigations showed that TSA inhibits IL-1β release by inhibiting tubulin dependent lysosomal exocytosis without affecting its transcription and maturation. Nocodazole (known acetylation inhibitor) pre-treatment inhibited TSA effect on IL-1β secretion in high glucose stimulated macrophages. Overall, our findings indicate that sustained HDAC6 expression in diabetic wounds contributes to impaired healing responses and HDAC6 may represent a new therapeutic target for diabetic wounds.

Identifiants

pubmed: 32712153
pii: S0925-4439(20)30251-9
doi: 10.1016/j.bbadis.2020.165903
pii:
doi:

Substances chimiques

Enzyme Inhibitors 0
Hydroxamic Acids 0
Indoles 0
Interleukin-1beta 0
Lipopolysaccharides 0
Interleukin-10 130068-27-8
tubastatin A 2XTSOX1NF8
Hdac6 protein, mouse EC 3.5.1.98
Histone Deacetylase 6 EC 3.5.1.98
Glucose IY9XDZ35W2
Nocodazole SH1WY3R615

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

165903

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest With the submission of this manuscript we would like to undertake that the above mentioned manuscript has not been published elsewhere, accepted for publication elsewhere or under editorial review for publication elsewhere; and that my Institute's BITS-Pilani, Hyderabad campus and co-authors are fully aware of this submission. The authors declare no conflicts of interest.

Auteurs

Kalyani Karnam (K)

Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad campus, India.

Kavitha Sedmaki (K)

Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad campus, India.

Pravesh Sharma (P)

Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad campus, India.

Ganesh Routholla (G)

Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad campus, India.

Sriharshini Goli (S)

Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad campus, India.

Balaram Ghosh (B)

Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad campus, India.

Venkata Vamsi Krishna Venuganti (VVK)

Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad campus, India.

Onkar Prakash Kulkarni (OP)

Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad campus, India. Electronic address: onkar@hyderabad.bits-pilani.ac.in.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH